Meenakshi Mission Hospital & Research Centre

Madurai, Tamil Nadu 625107

0 studies enrolling now · 3 studies all time

What they study most

Advanced Refractory Solid Tumors, Chronic Myeloid Leukemia (for Part B and C), Diffuse Large B-cell Lymphoma, Healthy (For Part A)

Studies at this site

• Selinexor (KPT-330) in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) — Running, not enrolling
• Safety and Anti-leukemic Activity of Vodobatinib (K0706) for Treatment of Ph+ CML Resistant/Intolerant to ≥3 Prior CML Therapies — Stopped early
• Clinical Study of Oral PI3K/mTOR Inhibitor in Patients With Advanced Refractory Solid Tumors — Paused